Dennis McGowan, MD
Orthopaedic Surgery · Kearney, NENPI 1598855298
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Medical Device Business Services, Inc. at 29.4% of the total. Reporting peaked in 2023 at $3,605 and has fallen 55.6% since, to $1,601 in 2025.
Across 91 payments — averaging $118.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$3K
- Osteonovus, Inc.$2K
- Centinel Spine, LLC$1K
- Orthofix Medical, Inc.$902
- Curvafix, Inc.$822
- Johnson & Johnson$687
- plus $3K from 27 others
What the payments were for
- Consulting fees$8758%
- Travel & lodging$5,26649%
- Food & beverage$4,61443%
- Entertainment$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 14 | $3,184 |
| Osteonovus, Inc. | 9 | $1,522 |
| Centinel Spine, LLC | 5 | $1,196 |
| Orthofix Medical, Inc. | 7 | $902 |
| Curvafix, Inc. | 7 | $822 |
| Johnson & Johnson | 6 | $687 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $456 |
| Innovation Technologies Inc | 2 | $258 |
| Integra Lifesciences Corporation | 4 | $197 |
| Cerapedics Inc. | 3 | $161 |
| Ulrich Medical USA, Inc. | 2 | $133 |
| Kerecis Limited | 3 | $129 |
| Choice Spine, LLC | 1 | $125 |
| Kyocera Medical Technologies, Inc. | 1 | $113 |
| Spinal Balance Inc | 1 | $104 |
| Organogenesis Inc. | 1 | $101 |
| Irhythm Technologies, Inc. | 1 | $99 |
| Vertex | 3 | $80 |
| Innovasis Inc | 1 | $75 |
| Sanara Medtech Inc. | 1 | $65 |
| Spineology Inc. | 1 | $61 |
| Integrity Implants Inc. | 1 | $58 |
| Radius Health, Inc. | 2 | $42 |
| Si-bone, Inc. | 3 | $40 |
| Polynovo North America LLC | 2 | $38 |
| Stryker | 1 | $36 |
| Zimmer Biomet | 1 | $31 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Linvatec Corporation | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Lifenet Health | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$2,043
- NovoGro$1,276
- PRODISC L$1,115
- M6-C Artificial Cervical Disc$794
- CurvaFix IM Implant$646
- Irrisept$258
- Blackhawk Ti$125
- Boomerang$125
- Stratofuse$125
- Raven Lumbar Plate System$125
- Tiger Shark C$125
- LIBRA$104
How this compares
$10,824 in reported general payments places this provider in the 75th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Teriparatide | 12 | $20,851 |
| EliquisApixaban | 17 | $12,898 |
| XareltoRivaroxaban | 18 | $9,711 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 17 | $2,602 |
| Gabapentin | 94 | $1,413 |
| Celecoxib | 66 | $1,276 |
| Bumetanide | 16 | $464 |
| SotalolSotalol Hcl | 19 | $229 |
| Chlorthalidone | 19 | $162 |
| Amlodipine Besylate | 14 | $128 |
| Metoprolol Tartrate | 11 | $56 |
| Losartan Potassium | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $687 | $9,71118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 155 orthopaedic surgery providers in Nebraska.
Other orthopaedic surgery in Kearney
- Heber CrockettKearney$4.2M
- John WrightKearney$1.2M
- David HuebnerKearney$131K
- James MahalekKearney$11K
- Chris WilkinsonKearney$7K
- Patrick HarrisonKearney$6K
- Ryan DeblisKearney$5K
- Todd SekundiakElkhorn$7.3M
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$475K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.